日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-world analyses of major adverse cardiovascular events and mortality risk after androgen deprivation therapy initiation in black vs. white prostate cancer patients

对黑人和白人前列腺癌患者在开始雄激素剥夺疗法后主要不良心血管事件和死亡风险的真实世界分析

Moul, Judd W; Boldt-Houle, Deborah M; Roach, Mack 3rd

Patient Demographics and Major Adverse Cardiovascular Events after Androgen Deprivation Therapy for Prostate Cancer

前列腺癌患者接受雄激素剥夺疗法后的人口统计学特征和主要不良心血管事件

Wallis, Christopher J D; Chen, Kevin C; Atkinson, Stuart; Boldt-Houle, Deborah M

THU195 6-Month Subcutaneous Leuprolide Acetate Achieved And Maintained Hormonal And Clinical Suppression In All Weight Groups Of Children With Central Precocious Puberty

THU195 6个月皮下注射醋酸亮丙瑞林可使所有体重组的中枢性性早熟患儿达到并维持激素和临床抑制。

Umstattd Meyer, M Renée; Bridges, Christina N; Schmid, Thomas L; Hecht, Amelie A; Pollack Porter, Keshia M; Miller, Bradley S; Boldt-Houle, Deborah; Atkinson, Stuart N

Do attention-deficit/hyperactivity symptoms influence treatment outcome in gambling disorder?

注意力缺陷/多动症状是否会影响赌博障碍的治疗效果?

Fevang, L; Miller, Bradley S; Boldt-Houle, Debbie; Daugherty, Rhea; Atkinson, Stuart; Vintró-Alcaraz, C; Mestre-Bach, G; Granero, R; Gómez-Peña, M; Moragas, L; Fernández-Aranda, F; Potenza, M N; Jiménez-Murcia, S

Subcutaneous in situ gel delivered leuprolide acetate's consistent and prolonged drug delivery maintains effective testosterone suppression independent of age and weight in men with prostate cancer

皮下原位凝胶递送的醋酸亮丙瑞林可实现持续稳定的药物释放,从而在患有前列腺癌的男性中维持有效的睾酮抑制作用,且不受年龄和体重的影响。

Renzulli, Joseph F 2nd; Tagawa, Scott T; Atkinson, Stuart N; Boldt-Houle, Deborah M; Moul, Judd W